1. Home
  2. EXPO vs BHVN Comparison

EXPO vs BHVN Comparison

Compare EXPO & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXPO
  • BHVN
  • Stock Information
  • Founded
  • EXPO 1967
  • BHVN 2013
  • Country
  • EXPO United States
  • BHVN United States
  • Employees
  • EXPO N/A
  • BHVN N/A
  • Industry
  • EXPO Professional Services
  • BHVN Biotechnology: Pharmaceutical Preparations
  • Sector
  • EXPO Consumer Discretionary
  • BHVN Health Care
  • Exchange
  • EXPO Nasdaq
  • BHVN Nasdaq
  • Market Cap
  • EXPO 5.2B
  • BHVN 5.4B
  • IPO Year
  • EXPO 1990
  • BHVN 2017
  • Fundamental
  • Price
  • EXPO $95.87
  • BHVN $45.17
  • Analyst Decision
  • EXPO Strong Buy
  • BHVN Strong Buy
  • Analyst Count
  • EXPO 1
  • BHVN 13
  • Target Price
  • EXPO $120.00
  • BHVN $63.42
  • AVG Volume (30 Days)
  • EXPO 218.8K
  • BHVN 729.5K
  • Earning Date
  • EXPO 10-24-2024
  • BHVN 11-12-2024
  • Dividend Yield
  • EXPO 1.17%
  • BHVN N/A
  • EPS Growth
  • EXPO 4.07
  • BHVN N/A
  • EPS
  • EXPO 2.06
  • BHVN N/A
  • Revenue
  • EXPO $508,598,000.00
  • BHVN N/A
  • Revenue This Year
  • EXPO $5.52
  • BHVN N/A
  • Revenue Next Year
  • EXPO $5.48
  • BHVN $179.00
  • P/E Ratio
  • EXPO $46.54
  • BHVN N/A
  • Revenue Growth
  • EXPO 2.56
  • BHVN N/A
  • 52 Week Low
  • EXPO $68.70
  • BHVN $26.80
  • 52 Week High
  • EXPO $115.75
  • BHVN $62.21
  • Technical
  • Relative Strength Index (RSI)
  • EXPO 36.58
  • BHVN 38.20
  • Support Level
  • EXPO $93.43
  • BHVN $43.18
  • Resistance Level
  • EXPO $107.41
  • BHVN $54.53
  • Average True Range (ATR)
  • EXPO 3.22
  • BHVN 2.57
  • MACD
  • EXPO -0.36
  • BHVN -0.85
  • Stochastic Oscillator
  • EXPO 12.63
  • BHVN 16.86

About EXPO Exponent Inc.

Exponent Inc provides engineering and scientific consulting services on a project-by-project basis. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which accounts for the majority of revenue, provides servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Share on Social Networks: